View all news

    Janssen Receives Positive CHMP Opinion for SPRAVATO®▼ (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder

    12/11/2020
    Download(opens in new window)PDF 212 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com